BioTech

Inolex has announced it is to develop its US manufacturing facilities, with the new expansion set to replace the company’s current US production and warehouse operations. The expansion is set for completion in the second half of 2019 with a new flagship plant in Charlotte, North Carolina. David Plimpton, Inolex CEO, says, “This is a...

THOUSAND OAKS, Calif. and BRUSSELS, April 9, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. Foo

GlaxoSmithKline will partner with Merck KGaA, Darmstadt, to co-develop and co-commercialize the cancer immunotherapy candidate M7824 (bintrafusp alfa), through a collaboration that could generate more than €3.7 billion ($4.2 billion) for German Merck.

Gilead Sciences announced that it will provide free Truvada as PrEP for 200,000 people through 2030. Activists say Gilead is moving to protect Truvada revenue.

Spark Therapeutics (ONCE), a commercial gene therapy company, announced Friday that the European Commission has granted marketing authorization for LUXTURNA (voretigene neparvovec).

DUBLIN, March 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Ne

Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy

(GLOBE NEWSWIRE via COMTEX) -- Novartis International AG / Sandoz drives differentiated portfolio with deal to commercialize new treatment fo

Source: globenewswire.com MacroGenics Inc. has announced positive results from SOPHIA, a Phase 3 clinical study of margetuximab in HER2-positive metastatic breast cancer patients. Margetuximab is...

ROCKLAND, Mass. and NEW YORK, May 14, 2019 /PRNewswire/ -- BAVENCIO is the first anti-PD-L1 in combination with INLYTA approved by FDA for first-line treatmen